Blood test may personalize esophageal cancer therapy
Disease control
Recruiting now
This study explores whether monitoring tumor DNA in the blood (ctDNA) can help guide treatment for esophageal cancer. Researchers will give patients immunotherapy and chemotherapy, followed by chemoradiotherapy, and track ctDNA levels to see if they predict outcomes. The goal is …
Phase: NA • Sponsor: The Central Hospital of Lishui City • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC